Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 39 papers were listed this time. Here's a few in our areas of research interest:
Hamers FF, Rumeau-Pichon C. Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France. BMC Pediatr. 2012 Jun 8;12(1):60. [Epub ahead of print] PubMed PMID: 22681855.
Kourlaba G, Fragoulakis V, Maniadakis N. Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece: A Cost-Utility Analysis. Appl Health Econ Health Policy. 2012 Jun 5. [Epub ahead of print] PubMed PMID: 22667992.
Mullins CD, Hsiao FY, Onukwugha E, et al. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients. Cancer. 2012 Jun 15;118(12):3173-81. Epub 2011 Oct 21. PubMed PMID: 22020739.